imPulse™ Tor System Self-Directed Cuffless Blood Pressure Monitoring

AI/ML Algorithm Training and Validation for the imPulse™ Tor System Self-Directed Systolic & Diastolic Blood Pressure Monitor.

NCT05386654•Level 42 AI, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

AI-driven, Self-directed Blood Pressure Monitoring

Interventions

imPulse™ Tor System

Locations

United States

Locations (1)

UCD Sports Medicine

Sacramento, California, United States

Key Dates

Start Date

May 16, 2022

Primary Completion Date

August 23, 2022

Completion Date

August 30, 2022

Last Updated

March 23, 2023

Sponsors

Lead Sponsor

Level 42 AI, Inc.

Collaborators

University of California, Davis

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 23, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions